{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:44:11Z","timestamp":1780101851726,"version":"3.54.0"},"reference-count":59,"publisher":"Impact Journals, LLC","issue":"66","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2018,8,24]]},"DOI":"10.18632\/oncotarget.25961","type":"journal-article","created":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T19:12:42Z","timestamp":1535137962000},"page":"32593-32608","source":"Crossref","is-referenced-by-count":19,"title":["Alendronate-induced disruption of actin cytoskeleton and inhibition of migration\/invasion are associated with cofilin downregulation in PC-3 prostate cancer cells"],"prefix":"10.18632","volume":"9","author":[{"given":"Sanna S.","family":"Virtanen","sequence":"first","affiliation":[{"name":"University of Turku, Institute of Biomedicine, FI-20520 Turku, Finland"},{"name":"Turku University of Applied Sciences, Health and Well-being, FI-20520 Turku, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamiko","family":"Ishizu","sequence":"additional","affiliation":[{"name":"University of Turku, Institute of Biomedicine, FI-20520 Turku, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jouko A.","family":"Sandholm","sequence":"additional","affiliation":[{"name":"Cell Imaging Core, Turku Centre for Biotechnology, University of Turku and \u00c5bo Akademi University, FI-20521 Turku, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliisa","family":"L\u00f6yttyniemi","sequence":"additional","affiliation":[{"name":"University of Turku, Department of Biostatistics, FI-20520 Turku, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Kalervo","family":"V\u00e4\u00e4n\u00e4nen","sequence":"additional","affiliation":[{"name":"University of Turku, Institute of Biomedicine, FI-20520 Turku, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna M.","family":"Tuomela","sequence":"additional","affiliation":[{"name":"University of Turku, Institute of Biomedicine, FI-20520 Turku, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pirkko L.","family":"H\u00e4rk\u00f6nen","sequence":"additional","affiliation":[{"name":"University of Turku, Institute of Biomedicine, FI-20520 Turku, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2018,8,24]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrc3055","article-title":"Cancer to bone: a fatal attraction","volume":"11","author":"McCauley","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"2","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.eururo.2012.09.007","article-title":"A phase 3, double-blind, randomised, parallel-group, placebo-controlled study of oral weekly alendronate for the prevention of androgen deprivation bone loss in nonmetastatic prostate cancer: the Cancer and Osteoporosis Research with Alendronate and Leuprolide (CORAL) study","volume":"63","author":"Consortium","year":"2013","journal-title":"Eur Urol"},{"key":"3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1124\/mol.56.1.131","article-title":"Farnesol and geranylgeraniol prevent activation of caspases by aminobisphosphonates: biochemical evidence for two distinct pharmacological classes of bisphosphonate drugs","volume":"56","author":"Rogers","year":"1999","journal-title":"Mol Pharmacol"},{"key":"4","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1359\/jbmr.1997.12.9.1358","article-title":"Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5\u2019-(beta, gamma-dichloromethylene) triphosphate, by mammalian cells","volume":"12","author":"Rogers","year":"1997","journal-title":"J Bone Miner Res"},{"key":"5","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/BF00299317","article-title":"The effects of bisphosphonates on the resorption cycle of isolated osteoclasts","volume":"55","author":"V\u00e4\u00e4n\u00e4nen","year":"1994","journal-title":"Calcif Tissue Int"},{"key":"6","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1042\/CBI20090288","article-title":"Inhibition of GGTase-I and FTase disrupts cytoskeletal organization of human PC-3 prostate cancer cells","volume":"34","author":"H\u00e4rk\u00f6nen","year":"2010","journal-title":"Cell Biol Int"},{"key":"7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/abbi.1999.1502","article-title":"Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase","volume":"373","author":"Rodan","year":"2000","journal-title":"Arch Biochem Biophys"},{"key":"8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0022-3565(24)38786-5","article-title":"Structure-activity relationships for inhibition of farnesyl diphosphate synthaseand inhibition of bone resorptionby nitrogen-containing bisphosphonates","volume":"296","author":"Rogers","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1471-2407-6-60","article-title":"Zoledronic acid treatment impairs protein geranyl-geranylation for biological effects in prostatic cells","volume":"6","author":"S\u00e9ronie-Vivien","year":"2006","journal-title":"BMC Cancer"},{"key":"10","first-page":"3890","article-title":"Bisphosphonates inhibit prostate and breast carcinoma cell adhesion to unmineralized and mineralized bone extracellular matrices","volume":"57","author":"Clezardin","year":"1997","journal-title":"Cancer Res"},{"key":"11","first-page":"2949","article-title":"Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases","volume":"60","author":"Cl\u00e9zardin","year":"2000","journal-title":"Cancer Res"},{"key":"12","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1038\/sj.bjc.6600925","article-title":"New insights into the actions of bisphosphonate zoledronic acid in breast cancer cells by dual RhoA-dependent and -independent effects","volume":"88","author":"Soria","year":"2003","journal-title":"Br J Cancer"},{"key":"13","first-page":"2708","article-title":"Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway","volume":"62","author":"Lakkakorpi","year":"2002","journal-title":"Cancer Res"},{"key":"14","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/CAD.0b013e3282f632bf","article-title":"Bisphosphonate-induced ATP analog formation and its effect on inhibition of cancer cell growth","volume":"19","author":"M\u00f6nkk\u00f6nen","year":"2008","journal-title":"Anticancer Drugs"},{"key":"15","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/sj.bjp.0706628","article-title":"A new endogenous ATP analog (ApppI) inhibits the mitochondrial adenine nucleotide translocase (ANT) and is responsible for the apoptosis induced by nitrogen-containing bisphosphonates","volume":"147","author":"M\u00f6nkk\u00f6nen","year":"2006","journal-title":"Br J Pharmacol"},{"key":"16","first-page":"2602","article-title":"Bisphosphonate treatment inhibits the growth of prostate cancer cells","volume":"61","author":"Guenette","year":"2001","journal-title":"Cancer Res"},{"key":"17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1471-2407-8-81","article-title":"Alendronate decreases orthotopic PC-3 prostate tumor growth and metastasis to prostate-draining lymph nodes in nude mice","volume":"8","author":"H\u00e4rk\u00f6nen","year":"2008","journal-title":"BMC Cancer"},{"key":"18","first-page":"1851","article-title":"Synergistic growth inhibition of PC3 prostate cancer cells with low-dose combinations of simvastatin and alendronate","volume":"35","author":"Palau","year":"2015","journal-title":"Anticancer Res"},{"key":"19","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2174\/187152012799014977","article-title":"Potential anticancer properties of bisphosphonates: insights from preclinical studies","volume":"12","author":"Clezardin","year":"2012","journal-title":"Anticancer Agents Med Chem"},{"key":"20","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s00262-008-0482-9","article-title":"Zoledronic acid modulates antitumoral responses of prostate cancer-tumor associated macrophages","volume":"57","author":"Pisa","year":"2008","journal-title":"Cancer Immunol Immunother"},{"key":"21","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.2174\/092986708784310468","article-title":"Aminobisphosphonates as new weapons for gammadelta T Cell-based immunotherapy of cancer","volume":"15","author":"Dieli","year":"2008","journal-title":"Curr Med Chem"},{"key":"22","doi-asserted-by":"crossref","first-page":"5557","DOI":"10.4049\/jimmunol.1402200","article-title":"Adoptive immunotherapy of epithelial ovarian cancer with V\u03b39V\u03b42 T cells, potentiated by liposomal alendronic acid","volume":"193","author":"Maher","year":"2014","journal-title":"J Immunol"},{"key":"23","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1158\/1078-0432.CCR-03-0325","article-title":"Zoledronic acid inhibits visceral metastases in the 4T1\/luc mouse breast cancer model","volume":"10","author":"Yoneda","year":"2004","journal-title":"Clin Cancer Res"},{"key":"24","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1158\/0008-5472.540.65.2","article-title":"Alendronate inhibits intraperitoneal dissemination inovarian cancer model","volume":"65","author":"Murata","year":"2005","journal-title":"Cancer Res"},{"key":"25","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1349-7006.2005.00062.x","article-title":"Regulation of cancer cell motility through actin reorganization","volume":"96","author":"Takenawa","year":"2005","journal-title":"Cancer Sci"},{"key":"26","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.1158\/1078-0432.CCR-15-0328","article-title":"Molecular pathways: new signaling considerations when targeting cytoskeletal balance to reduce tumor growth","volume":"21","author":"Martin","year":"2015","journal-title":"Clin Cancer Res"},{"key":"27","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3892\/br.2015.494","article-title":"Role of cellular cytoskeleton in epithelial-mesenchymal transition process during cancer progression","volume":"3","author":"Xiang","year":"2015","journal-title":"Biomed Rep"},{"key":"28","first-page":"15","article-title":"Cytoskeleton targeting value in prostate cancer treatment","volume":"2","author":"Kyprianou","year":"2014","journal-title":"Am J Clin Exp Urol"},{"key":"29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0968-0004(99)01511-X","article-title":"Regulating actin-filament dynamics","volume":"25","author":"Bamburg","year":"2000","journal-title":"Trends Biochem Sci"},{"key":"30","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nrc2148","article-title":"The cofilin pathway in breast cancer invasion and metastasis","volume":"7","author":"Condeelis","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"31","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nrm3609","article-title":"Functions of cofilin in cell locomotion and invasion","volume":"14","author":"Condeelis","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"key":"32","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1242\/jcs.187849","article-title":"Cellular functions of the ADF\/cofilin family at a glance","volume":"129","author":"Frame","year":"2016","journal-title":"J Cell Sci"},{"key":"33","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1158\/0008-5472.CAN-13-3058","article-title":"Cofilin drives cell-invasive and metastatic responses to TGF-\u03b2 in prostate cancer","volume":"74","author":"Kyprianou","year":"2014","journal-title":"Cancer Res"},{"key":"34","doi-asserted-by":"crossref","first-page":"537","DOI":"10.5301\/tj.5000569","article-title":"Study on the significance of Cofilin 1 overexpression in human bladder cancer","volume":"103","author":"Wang","year":"2017","journal-title":"Tumori"},{"key":"35","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.humpath.2010.07.019","article-title":"Overexpression of cofilin 1 can predict progression-free survival in patients with epithelial ovarian cancer receiving standard therapy","volume":"42","author":"Aoki","year":"2011","journal-title":"Hum Pathol"},{"key":"36","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/cas.13181","article-title":"Immune-complex level of cofilin-1 in sera is associated with cancer progression and poor prognosis in pancreatic cancer","volume":"108","author":"Nomura","year":"2017","journal-title":"Cancer Sci"},{"key":"37","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.18632\/oncotarget.3471","article-title":"Potential crosstalk between cofilin-1 and EGFR pathways in cisplatin resistance of non-small-cell lung cancer","volume":"6","author":"Klamt","year":"2015","journal-title":"Oncotarget"},{"key":"38","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1128\/MCB.17.3.1129","article-title":"Expression of constitutively active alpha-PAK reveals effects of the kinase on actin and focal complexes","volume":"17","author":"Lim","year":"1997","journal-title":"Mol Cell Biol"},{"key":"39","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/12963","article-title":"Activation of LIM-kinase by Pak1 couples Rac\/Cdc42 GTPase signalling to actin cytoskeletal dynamics","volume":"1","author":"Gill","year":"1999","journal-title":"Nat Cell Biol"},{"key":"40","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1152\/physrev.00002.2004","article-title":"Paxillin: adapting to change","volume":"84","author":"Turner","year":"2004","journal-title":"Physiol Rev"},{"key":"41","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/10623320701347187","article-title":"Zoledronate inhibits alphavbeta3 and alphavbeta5 integrin cell surface expression in endothelial cells","volume":"14","author":"Castronovo","year":"2007","journal-title":"Endothelium"},{"key":"42","first-page":"927","article-title":"Incadronate induces cell detachment and apoptosis in prostatic PC-3 cells","volume":"27","author":"Hirano","year":"2007","journal-title":"Anticancer Res"},{"key":"43","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1172\/JCI118841","article-title":"Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices","volume":"98","author":"Papapoulos","year":"1996","journal-title":"J Clin Invest"},{"key":"44","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1083\/jcb.117.2.347","article-title":"Regulation of intracellular actin polymerization by prenylated cellular proteins","volume":"117","author":"Smith","year":"1992","journal-title":"J Cell Biol"},{"key":"45","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1091\/mbc.e04-07-0555","article-title":"Actin-depolymerizing factor and cofilin-1 play overlapping roles in promoting rapid F-actin depolymerization in mammalian nonmuscle cells","volume":"16","author":"Lappalainen","year":"2005","journal-title":"Mol Biol Cell"},{"key":"46","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10555-008-9168-1","article-title":"Pak protein kinases and their role in cancer","volume":"28","author":"Field","year":"2009","journal-title":"Cancer Metastasis Rev"},{"key":"47","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1038\/onc.2014.206","article-title":"quantitative phosphoproteomic profiling identifies novel regulators of castration-resistant prostate cancer growth","volume":"34","author":"Flores-Morales","year":"2015","journal-title":"Oncogene"},{"key":"48","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1021\/pr8006478","article-title":"Temporal quantitative proteomics by iTRAQ 2D-LC-MS\/MS and corresponding mRNA expression analysis identify post-transcriptional modulation of actin-cytoskeleton regulators during TGF-beta-Induced epithelial-mesenchymal transition","volume":"8","author":"Omenn","year":"2009","journal-title":"J Proteome Res"},{"key":"49","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.3892\/or.2016.4625","article-title":"The role of cofilin-l in vulvar squamous cell carcinoma: a marker of carcinogenesis, progression and targeted therapy","volume":"35","author":"Wu","year":"2016","journal-title":"Oncol Rep"},{"key":"50","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1080\/15384101.2015.1036203","article-title":"BRCA1 deficiency in ovarian cancer is associated with alteration in expression of several key regulators of cell motility - A proteomics study","volume":"14","author":"Roy","year":"2015","journal-title":"Cell Cycle"},{"key":"51","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.humpath.2016.06.020","article-title":"Association of epithelial-mesenchymal transition and nuclear cofilin with advanced urothelial cancer","volume":"57","author":"Kyprianou","year":"2016","journal-title":"Hum Pathol"},{"key":"52","first-page":"6538","article-title":"Bisphosphonates inhibit angiogenesisand testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats","volume":"62","author":"Cl\u00e9zardin","year":"2002","journal-title":"Cancer Res"},{"key":"53","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3109\/07853899309147299","article-title":"Bisphosphonates in the treatment of metabolic bone diseases","volume":"25","author":"Balena","year":"1993","journal-title":"Ann Med"},{"key":"54","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ijpharm.2010.10.046","article-title":"Self-assembly nanoparticles for the delivery of bisphosphonates into tumors","volume":"403","author":"De Rosa","year":"2011","journal-title":"Int J Pharm"},{"key":"55","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.biotechadv.2011.06.018","article-title":"New self-assembly nanoparticles and stealth liposomes for the delivery of zoledronic acid: a comparative study","volume":"30","author":"La Rotonda","year":"2012","journal-title":"Biotechnol Adv"},{"key":"56","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.nano.2011.03.004","article-title":"Nanotechnologies to use bisphosphonates as potent anticancer agents: the effects of zoledronic acid encapsulated into liposomes","volume":"7","author":"Abbruzzese","year":"2011","journal-title":"Nanomedicine (Lond)"},{"key":"57","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Im age to ImageJ: 25 years of image analysis","volume":"9","author":"Eliceiri","year":"2012","journal-title":"Nat Methods"},{"key":"58","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.tcb.2004.12.001","article-title":"FRAP analysis of binding: proper and fitting","volume":"15","author":"McNally","year":"2005","journal-title":"Trends Cell Biol"},{"key":"59","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Schmittgen","year":"2001","journal-title":"Methods"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.25961","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T15:08:52Z","timestamp":1751814532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.25961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,24]]},"references-count":59,"journal-issue":{"issue":"66","published-print":{"date-parts":[[2018,8,24]]}},"alternative-id":["25961","30220968"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.25961","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,24]]}}}